Micromodule 2 - Pharmacotherapy for the Treatment of Type 2 Diabetes and Obesity

A System-Based and Scalable Quality Improvement Initiative to Improve Care and Outcomes in High-Risk Patients With Type 2 Diabetes and Obesity

Provided by Boston University School of Medicine in collaboration with Clinical Care Options, Practicing Clinicians Exchange, and RealCME.

Acknowledgment

This activity is supported by an educational grant from Lilly.

Target Audience

This program is intended for primary care providers including internal and family medicine physicians, nurse practitioners, physician associates/physician assistants, nurses, registered dietitians, and pharmacists as well as population health managers and others involved in the care delivery of patients living with type 2 diabetes and obesity.

Learning Objectives

Upon completion of this activity, learners should be able to:

  • Discuss type 2 diabetes pharmacotherapy that goes beyond gluco-centric models
    and is patient centered, cardioprotective, and weight centric
Course summary
Available credit: 
  • 0.50 AAPA Category I CME
  • 0.50 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.50 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
  • 0.50 Participation
Course opens: 
08/04/2022
Course expires: 
08/03/2023
Rating: 
0

Disclosure of Conflicts of Interest

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 
 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

 

Faculty

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity

Sara Alexanian, MD, Faculty, has no relevant financial relationships to disclose.

Lisa Caruso, MD, MPH, Faculty, has no relevant financial relationships to disclose.

Samar Hafida, MD, Co-Course Director, has no relevant financial relationships to disclose.

Kevin J. Horbowicz, PharmD, BCPS, Faculty, has disclosed that he has individual publicly traded stocks and stock options from Merck.

Linda Baer, MSPH, CHCP, Planner, has no relevant financial relationships to disclose.

Emily Jansen, MPH, Planner, has no relevant financial relationships to disclose.

Lorena Loci, MSN, NP, Content Co-Chair, Nurse Advisor, has no relevant relationships to disclose.

Katelyn O’Brien, PharmD, Content Co-Chair, has no relevant relationships to disclose.

Ivania Rizo, MD, Co-Course Director, has no relevant financial relationships to disclose.

Charles T. Williams, MD, Faculty, has no relevant relationships to disclose.

Natalie Sanfratello, MPH, Planner, has no relevant financial relationships to disclose.

Sophia Kelley, MBA, Planner, has no relevant financial relationships to disclose.

Cara Blair, Planner, has no relevant financial relationships to disclose.

Ruth Cohen, Planner, has no relevant financial relationships to disclose.

Robin Black, PharmD, Planner, has no relevant financial relationships to disclose.

Dave Faldmo, PA-C, MPAS, Planner, has no relevant financial relationships to disclose.

Corinne Aia, MS, RD, CDCES Planner, has no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by healthcare professionals without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Accreditation Information

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation of Credit

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 0.50 contact hours (0.050 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number – JA4008176-0000-22-176-H01-P

Type of Activity: Application

Upon successfully completing this actitivy, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Registered Dieticians/Dietetic Technicians, Registered

Credit Designation

Registered Dietitians/Dietetic Technicians, Registered will receive 0.50 Continuing Professional Education units (CPEUs) for completion of this activity.

Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.

In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AAPA Credit Designation

Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until August 3, 2023. PAs should only claim credit commensurate with the extent of their participation.

CME Accreditation

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Boston University School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NCPD Accreditation

Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

 Contact Hours: 0.50 of which 0.50 are eligible for pharmacology credit 

If you are a Pharmacist, Registered Dietician, or Dietetic Technician, please follow the below instructions for claiming credit 

1. Proceed through course until the post-test

2. When you arrive at the post-test, follow the link to CCO's website

3. Complete the post-test and evaluation on CCO's website 

 

Available Credit

  • 0.50 AAPA Category I CME
  • 0.50 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.50 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
  • 0.50 Participation
Please login or register to take this course.